EICHORCondition: Non Small Cell Lung Cancer · Lung Cancer · Nsclc · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to see if Durvalumab and radiation therapy can delay the worsening of disease in patients with non-small cell lung cancer normally treated with sequential chemotherapy followed by radiation therapy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Baptist Alliance Miami Cancer Institute | Miami, Florida, United States | — |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge, New Jersey, United States | — |
| Memorial Sloan Kettering Monmouth | Middletown, New Jersey, United States | — |
| Memorial Sloan Kettering Bergen | Montvale, New Jersey, United States | — |
| Memorial Sloan Kettering Cancer Commack | Commack, New York, United States | — |
| Memorial Sloan Kettering Westchester | Harrison, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Memorial Sloan Kettering Nassau | Uniondale, New York, United States | — |
| Lehigh Valley Health Network | Allentown, Pennsylvania, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03999710